| Novartis–GSK: ofatumumab, 201508 acquisition of all rights to all indications for Arzerra for up to $1.034b by Novartis |
2015-08-21 |
| Nanodigmbio–Genetrix (ES): genomic reagents, 201508– distribution of Sygnis TruePrime + SunScript RT products in China by Nanodigmbio |
2015-08-20 |
| EBS Technologies–Earlybird: investment, 201508 financing round totalling €1.1m led by returning investors Earlybird + HTGF |
2015-08-19 |
| EBS Technologies–High-Tech Gründerfonds: investment, 201508 financing round totalling €1.1m led by returning investors Earlybird + HTGF |
2015-08-19 |
| EBS Technologies–PERSON: investment, 201508 financing round €1.1m led by Earlybird + HTGF plus 3 private investors incl R Christine |
2015-08-19 |
| EBS Technologies–SEVERAL: investment, 201508 financing round €1.1m led by Earlybird + HTGF plus 3 private investors incl R Christine |
2015-08-19 |
| Kapa Biosystems–Roche: investment, 201508 acquisition €na by Roche |
2015-08-19 |
| Celsus Therapeutics–SEVERAL: investment, 201508– private placement $75m net $70m of ADSs led by Deerfield |
2015-08-18 |
| Kuros–Huntsworth: public relations, 201508 service existent media relations by Citigate Dewe Rogerson |
2015-08-18 |
| Kuros–SEVERAL: investment, 201508 financing round CHF15m led by LifeCare Partners + Life Sciences Partners |
2015-08-18 |
| GeneWeave–Roche: investment, 201508– acquisition $190m upfront + $235m product related milestones |
2015-08-13 |
| Checkmate–Cytos Biotechnology: cancer immunotherapy, 201508– excl license to CYT003 + VLP technology for cancer $90m milestones + royalties |
2015-08-12 |
| Checkmate–SEVERAL: investment, 201508 financing round Series A $20m from Sofinnova Ventures + venBio |
2015-08-12 |
| Sanofi–Apeiron: cancer immunotherapy, 201508– collab r+d small-molecules of Evotec + Apeiron + Sanofi |
2015-08-10 |
| Sanofi–Evotec: cancer immunotherapy, 201508– collab r+d small-molecules of Evotec + Apeiron + Sanofi |
2015-08-10 |
| JenaValve–SEVERAL: investment, 201508 financing round $26.5m including Gimv |
2015-08-07 |
| Nomad Bioscience–Denka: investment, 201508–201708 acquisition up to €75m of 51% share in Icon Genetics GmbH + after 2y acquiring rest by Denka |
2015-08-07 |
| Sanofi–Evotec: drug discovery, 201508– collab research beta cell replacement therapy for diabetes |
2015-08-07 |
| Deutsche Biotech Innovativ–Kirchhoff Consult: public relations, 201508 service existent by Kirchhoff Consult AG |
2015-08-06 |
| MorphoSys–G7 Therapeutics: therapeutic antibodies, 201508– collab to develop therap ABs targeting GPCRs |
2015-08-04 |
| AdvanceCor–SEVERAL: investment, 201508 2nd financing round €2.2m led by MIG AG inkl Bayern Kapital + Bio-M + HTGF + KfW Bank + founders |
2015-08-01 |
| Amgen–Novartis: CNS drugs, 201508– collab ww developm + commercialisation drugs for Alzheimer’s + migraine |
2015-08-01 |
| Deutsche Biotech Innovativ–SEVERAL: investment, 201508–201511 capital increase €1.6m 49k new shares €33.5/share out of 596.4k shares on public offer |
2015-08-01 |
| Novartis–CSL: investment, 201507 acquisition $275m of Novartis influenza vaccine business by CSL Ltd |
2015-07-31 |
| Santhera–SEVERAL: investment, 201507–201508 capital increase $28.6m |
2015-07-31 |
| DSM–Evonik: animal feed, 201507– collab developm algae-based production of omega-3 fatty acids for animal nutrition |
2015-07-29 |
| Mereo BioPharma–Novartis: investment, 201507 Novartis receives equity stake in consideration for acquisition of 3 programmes from Novartis by Mereo |
2015-07-29 |
| Mereo BioPharma–SEVERAL: investment, 201507 financing round $118m from Woodford + Invesco Perpetual at launch of company |
2015-07-29 |
| Apogenix–R-Biopharm: cancer companion diagnostics, 201507– collab developm CDx for Apogenix’ CD95 ligand inhibitor APG101 |
2015-07-28 |
| Boehringer–Hanmi: kinase inhibitor, 201507–201609 TERMINATED license to HM61713 ww excl KR + CN + HK with $50m upfront + $680m milestones + royalties |
2015-07-28 |
| Boehringer–Hikma: investment, 201507– acquisition of Roxane Labs $2.65b w $1.18m in cash + 40m new Hikma shares + addit $125m milestones |
2015-07-28 |
| Hikma–Boehringer: investment, 201507– acquisition 40m new shares £940m representing 16.71% as part of sale of Roxane by BI to Hikma |
2015-07-28 |
| MRC Technology–Univ Göttingen: therapeutic antibodies, 201507– collab developm ABs targeting amyloid beta 4-x for Alzheimer’s Disease |
2015-07-28 |
| Pieris–SEVERAL: investment, 201507 public offering $25m+$3.3m with 9.1m+1.2m new shares common stock $2.75/share |
2015-07-28 |
| Protembis–SEVERAL: investment, 201507 seed financing round 7-digit € incl Innovationsstarter Fonds + Geratherm + angel investors |
2015-07-28 |
| Leon-Nanodrugs–Albany Private Equity: investment, 201507 financing round Series A 1st closing totalling €18.5m incl Albany Private Equity Holding |
2015-07-27 |
| Leon-Nanodrugs–CD-Venture: investment, 201507 financing round Series A 1st closing totalling €18.5m incl CD-Venture |
2015-07-27 |
| Leon-Nanodrugs–LifeCare Partners: investment, 201507 financing round Series A 1st closing totalling €18.5m incl LifeCare Partners |
2015-07-27 |
| Leon-Nanodrugs–MJR PharmJet: nanoparticle drug delivery technology, 201507 collab existent |
2015-07-27 |
| Leon-Nanodrugs–OTHER: investment, 201507 financing round Series A 1st closing totalling €18.5m incl non-disclosed German Family Office |
2015-07-27 |
| Leon-Nanodrugs–SEVERAL: investment, 201507 financing round Series A 1st closing €18.5m led by TVM Capital Life Science |
2015-07-27 |
| Leon-Nanodrugs–Signet Healthcare Partners: investment, 201507 financing round Series A 1st closing totalling €18.5m incl Signet |
2015-07-27 |
| Leon-Nanodrugs–TVM: investment, 201507 financing round Series A 1st closing totalling €18.5m led by TVM Capital Life Science |
2015-07-27 |
| Merck (DE)–Celares: protein pegylation services, 201507– collab Merck Millipore offering PEG services tog with Celares GmbH |
2015-07-27 |
| Medigene–QVT: investment, 201507 QVT owns 15.6% of Medigene shares after capital increase |
2015-07-25 |
| Poxel–MacDougall Biomedical Communications: public relations, 201507 service existent IR + PR in EU + US |
2015-07-24 |
| Scienion–Anteo Technologies: protein microarray technology, 201507– collab developm protein microarray consumables using Mix&Go technology |
2015-07-24 |
| BeneChill–Odlander Fredrikson: investment, 201507 existent investment listed on HealthCap web site |
2015-07-23 |
| Merck (DE)–BioMed X: pharma research, 201507– collab Merck Serono extension funding two cancer research groups at BioMed X |
2015-07-23 |
| Cevec–SEVERAL: investment, 201507 financing round €4.5m from Peppermint + Creathor Venture + NRW.Bank + Investtodate et al |
2015-07-22 |
| Leukocare–LifeCare Partners: investment, 201507 financing round led by LifeCare Partners + incl new + existing investors |
2015-07-22 |
| Leukocare–SEVERAL: investment, 201507 financing round led by LifeCare Partners + incl new + existing investors |
2015-07-22 |
| Memo Therapeutics–SEVERAL: investment, 201507 financing round Series A CHF2.3m from Swiss investors incl EVA Basel + Redalpine + Zürcher Kantonalbank |
2015-07-22 |
| Merck (DE)–Genedata: bioinformatics, 201507– supply Merck Serono implements Genedata Biologics as workflow platform for biopharma RnD |
2015-07-22 |
| Allergan–Molecular Partners: ophthalmics, 201507– collab expansion of DARPin alliance in ophthalmology |
2015-07-21 |
| Anagnostics–Cube Dx: investment, 201507 acquisition of all assets of Anagnostics Bioanalysis GmbH by Cube Dx GmbH |
2015-07-21 |
| Medigene–Aviva: investment, 201507 acquisition 1.97m shares by Aviva plc representing 10.01% of Medigene shares after capital increase |
2015-07-20 |
| BioAnalytica GenoType–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services |
2015-07-16 |
| Bioarray (ES)–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services |
2015-07-16 |
| Cialab (ES)–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services |
2015-07-16 |
| Genetadi Biotech–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services |
2015-07-16 |
| Genycell–Sophia Genetics: bioinformatics, 201507– distribution of Sophia DDM platform for clinical NGS data analysis in Iberia by Genycell |
2015-07-16 |
| Immunocore–Credit Suisse: investment banking, 201507 supply service Credit Suisse is advisor on $320m Series A round |
2015-07-16 |
| Immunocore–Malin Corp: investment, 201507 financing round Series A totalling $320m (£205m) incl new investor Malin Corp plc |
2015-07-16 |
| Immunocore–SEVERAL: investment, 201507 financing round Series A $320m (£205m) private from new + existing investors |
2015-07-16 |
| Piqur Therapeutics–SEVERAL: investment, 201507 financing round Series A2 CHF18m incl returning investor Versant Ventures |
2015-07-16 |
| Piqur Therapeutics–Versant Ventures: investment, 201507 financing round Series A2 totalling CHF18m incl returning investor Versant Ventures |
2015-07-16 |
| Accurate Mass Scientific–CovalX: mass spectrometry, 201507– collab AMS new Australian distributor of CovalX High-Mass systems + CRO analytics services |
2015-07-15 |
| Canbridge Life Sciences–Apogenix: cancer drug, 201507– license developm + commercialisation of APG101 in Greater China |
2015-07-15 |
| Volution Immuno Pharmaceuticals–Celsus Therapeutics: investment, 201508– reverse merger acqu of VIP by Celsus to be renamed Akari Therapeutics |
2015-07-13 |
| Apceth–Univ Cologne: T-cell immunotherapy, 201507– collab with CMMC use of MSCs for local activation of CAR T-cells within tumours |
2015-07-10 |
| Insilico Biotechnology–SEVERAL: investment, 201507 capital increase |
2015-07-10 |
| SGS–Northern Exposure PR: public relations, 201507 service existent for SGS Life Sciences by NEPR |
2015-07-10 |
| JeNaCell–Evonik: investment, 201507 financing round Series A incl new investor Evonik Industries |
2015-07-09 |
| JeNaCell–High-Tech Gründerfonds: investment, 201507 financing round Series A incl existing investor HTGF |
2015-07-09 |
| JeNaCell–SEVERAL: investment, 201507 financing round Series A from Evonik + bm-t + Sparkasse Jena + HTGF + STIFT |
2015-07-09 |
| InSphero–HP Wild Holding: investment, 201507 Series C financing CHF20m from HP Wild Holding AG |
2015-07-08 |
| Qiagen–Seegene: molecular diagnostics, 201507– collab ww marketing validated multi-plexed Seegene PCR tests for QIAsymphony RGQ MDx system |
2015-07-08 |
| Cassiopea–Cosmo Pharmaceuticals: investment, 201507 existent 45.4% shareholder after spin-off of Cassiopea from Cosmo via IPO at SIX |
2015-07-06 |
| Cellca–Sartorius: investment, 201507 acquisition of Cellca GmbH by Sartorius Stedim Biotech |
2015-07-02 |
| Neovacs–MC Services: public relations, 201507 service existent by MC Services IR in Germany |
2015-07-02 |
| Actelion–Qlucore: bioinformatics, 201507– license 3y to Omics Explorer s/w after using it since 2011 |
2015-07-01 |
| Biotest–Cevec: rec protein production technology, 201507– license to CAP Go technology to Biotest AG |
2015-07-01 |
| GNA Biosolutions–Instinctif Partners: public relations, 201507 service existent by Instinctif Partners |
2015-07-01 |
| GNA Biosoutions–SEVERAL: investment, 201507 financing round Series B €6m led by new investor Robert Bosch Venture Capital GmbH |
2015-07-01 |
| Seres Therapeutics–Nestlé: investment, 201507 equity investment by Nestlé Health Science |
2015-07-01 |
| TAmiRNA–EU (govt): grant, 201507– Horizon 2020 SME Instrument Phase I Funding for collab with IPF Vienna |
2015-07-01 |
| Spinifex Pharmaceuticals–Novartis: investment, 201506– acquisition €na ANNOUNCED |
2015-06-29 |
| Actelion–Max Planck: vaccine technology, 201506 license excl synthetic carbohydrate vaccines for new Vaxillion joint venture from + with Max Planck |
2015-06-26 |
| Qiagen–Zörgiebel Group: molecular diagnostics, 201506– collab founding joint venture Biotye Innovation GmbH to develop MDx companion diagnostics |
2015-06-26 |
| Vaxxilon–Actelion: investment, 201506 founding w Max Planck + Actelion as majority owner w committed funding of €30m over 4y in tranches |
2015-06-26 |
| BioNTech–Siemens: cancer vaccine, 201506– collab developm + construction automated production facility for IVAC products Siemens Process Automation |
2015-06-25 |
| BioNTech–Strüngmann Group: investment, 201506 existent Strüngman family office is majority shareholder of BioNTech AG |
2015-06-25 |
| Gladstone Institutes–Thermo Fisher: grant, 201506– sponsoring of new Thermo Fisher Proteomics Facility for Disease Target Discovery at Gladstone |
2015-06-24 |
| Gladstone Institutes–Thermo Fisher: mass spectrometer, 201506 supply Orbitrap Fusion Tribrid system to new Proteomics Facility at Gladstone |
2015-06-24 |
| Gladstone Institutes–Thermo Fisher: mass spectrometer, 201506 supply TSQ Quantiva Triple Quad LC/MS system to new Proteomics Facility at Gladstone |
2015-06-24 |
| Thermo Fisher–Gladstone Institutes: mass spectrometry, 201506– collab establ new Thermo Fisher Proteomics Facility at Gladstone in collab w UCSF + QB3 |
2015-06-24 |
| Ankasa Regenerative–Avalon Ventures: investment, 201506 financing round Series A 1st tranche totalling $8.5m of $17m Series A led by Avalon Ventures |
2015-06-23 |
| Ankasa Regenerative–Correlation Ventures: investment, 201506 financing round Series A 1st tranche totalling $8.5m of $17m Series A incl Correlation |
2015-06-23 |
| Ankasa Regenerative–Heraeus: investment, 201506 financing round Series A 1st tranche totalling $8.5m of $17m Series A incl Heraeus Medical |
2015-06-23 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 21 22 23 ... 54 55 56 
Date![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lse-life-sciences-europe-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
